Table 2

Baseline and follow-up A1C, stratified by baseline A1C and intervention status and time to follow-up A1C

NIntervention ≤6 months no clinical inertiaNo intervention ≤6 months clinical inertia
Baseline A1C >7%1,168725 (62)443 (38)
 Baseline A1C (%)7.9 (7.3, 9.0)7.5 (7.2, 8.1)
 Baseline A1C (mmol/mol)63 (56, 75)58 (55, 65)
 Follow-up A1C (%)7.4 (6.9, 8.5)7.4 (6.9, 8.5)
 Follow-up A1C (mmol/mol)57 (52, 69)57 (52, 69)
 Time to follow-up A1C (months)5.0 (3.2, 8.6)
Baseline A1C >7.5% 679469 (69)210 (31)
 Baseline A1C (%)8.5 (7.9, 9.9)8.2 (7.8, 9.4)
 Baseline A1C (mmol/mol)69 (63, 85)66 (62, 79)
 Follow-up A1C (%)7.8 (7.1, 9.3)8.1 (7.1, 9.3)
 Follow-up A1C (mmol/mol)62 (54, 78)65 (54, 78)
 Time to follow-up A1C (months)4.9 (3.1, 9.0)
Baseline A1C >8% 429309 (72)120 (28)
 Baseline A1C (%)9.2 (8.5, 10.8)9.2 (8.4, 10.2)
 Baseline A1C (mmol/mol)77 (69, 95)77 (68, 88)
 Follow-up A1C (%)8.3 (7.3, 9.8)8.7 (7.3, 10.0)
 Follow-up A1C (mmol/mol)67 (56, 84)72 (56, 86)
 Time to follow-up A1C (months)5.0 (3.1, 9.3)
  • Data are presented as n (%) or median (IQR).